A BUSINESS INTELLIGENCE IN STEP WITH THE TIMES New Line Ricerche di Mercato has always been looking for effective and functional solutions to data analysis, which allow maximum flexibility in exploring information and creating simple analysis paths, to support the decision-making process of Pharmacies, Networks and Companies. Qlik®, a company founded in 1993 and which today has 33,000 customers in 100 countries, is New Line's technical partner. Qlik has innovated the way data is transformed by developing new technologies that are user-oriented and provide immediate visual summaries of complex databases. In 2019, thanks also to the advice and experiences shared by our customers, we further improved the Business Intelligence tool. The new version of Qlik allows you to extract large amounts of data, thanks to a powerful search engine that supports the production in a short time of complete tactical and strategic market analysis, with the maximum granularity of information in terms of KPIs, geographies and products . Privacy Policy | Cookie Policy | Contacts Copyright © 2021 New Line RdM Società Benefit SpA All rights reserved

NETWORK The very complex and constantly evolving scenario pushes the Industry to equip itself to be able to manage the relationship with the intermediate channel and the Pharmacy Networks in a more structured way . On the other hand, for Networks, whether they are real or virtual, it is increasingly important to have access to knowledge tools of market dynamics similar to those used by companies in order to manage their pharmacies efficiently. The role of New Line Always with and for the Pharmacy, New Line over the years has consolidated its role as a link in the partnership between Pharmacy and Industry, providing both players with specialized services aimed at monitoring and certifying sell-out, trends and market shares. Privacy Policy | Cookie Policy | Contacts Copyright © 2021 New Line RdM Società Benefit SpA All rights reserved

OVER 70,000 REFERENCES MONITORED EVERY MONTH Our working method is based on a targeted and continuous study of the channel, with the aim of evaluating: the real trends of the markets built in an open way , therefore including all new products and switches the structural characteristics competitive logic (concentration, seasonality, price positioning, assortments, stock, etc.) The analysis of product launches and innovations allows us to dynamically grasp and represent emerging markets. The organization of the databases is based on the ATC for the drug, while for the extra-drug, on the evaluation of the variables that influence the sell-out (need areas, methods of recruitment, type of components, categories of advice, positioning towards the consumer). Privacy Policy | Cookie Policy | Contacts Copyright © 2021 New Line RdM Società Benefit SpA All rights reserved